- recruitingTherapeutic confirmatory (Phase III)
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction (DAPA-PROTECTOR)
This study looks at whether a medicine called dapagliflozin can help protect the heart after a heart attack. Researchers want to see if taking this daily tablet for six months improves how well the heart pumps blood and prevents dangerous changes to the heart's shape and size.
France - recruiting
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
This study looks at a special machine called MOBYBOX used to help people with serious heart or lung problems. It aims to check how safe and effective this machine is in real-world situations, helping doctors understand if it's working well.
Germany - recruiting
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
This study looks at why some critically ill patients who need life support (ECMO) stay weak after leaving intensive care. We want to understand this weakness and how it affects their daily lives and well-being after severe heart and lung problems.
United Kingdom